TELO Telomir Pharmaceuticals, Inc.
Price Chart
Executive Summary
Telomir Pharmaceuticals disclosed the departure of CFO Alan Weichselbaum and the appointment of Andriy Mushak as fractional CFO via a consulting agreement with LMAM Consulting Group, LLC. The change is routine, with no disagreement cited, and the new CFO will be paid $6,000 per month. This is a standard officer transition for a small-cap pharma company with no material financial impact.
Actionable Insight
This is a routine CFO transition with no red flags. Monitor the next 10-Q for any signs of financial reporting delays or control weaknesses, but no immediate trading action is warranted.
Key Facts
- Alan Weichselbaum ceased serving as CFO effective June 6, 2026; departure not due to any disagreement with the company.
- Andriy Mushak, CPA, appointed as fractional CFO effective June 6, 2026, via a consulting agreement with LMAM Consulting Group, LLC.
- Mushak will be paid $6,000 per month for his services.
- Mushak has over 20 years of experience in SEC reporting, accounting compliance, and financial statement audits.
- No family relationships or material interests in transactions requiring disclosure were reported.
Financial Impact
Monthly cash compensation of $6,000 — immaterial relative to the company's $83M market cap.
Risk Factors
- Fractional CFO arrangement may signal limited internal finance resources at a small-cap company.
- No equity incentive disclosed for the new CFO, which could affect retention.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-027752 |
| Document: form8-k.htm | 0001493152-26-027752 |
| Document: 0001493152-26-027752-index-headers.html | 0001493152-26-027752 |
| Document: 0001493152-26-027752-index.html | 0001493152-26-027752 |
| Document: 0001493152-26-027752.txt | 0001493152-26-027752 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
4d ago
|
8-K
| $1.28 awaiting T+20 | awaiting T+20 | — | $1.26 (−1.18%) |
|
Apr 24, 2026
7w ago
|
8-K
| $1.40 $1.30 | ▼ −7.14% | ▼ −11.17% | $1.26 (−10.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access